BACKGROUND: The fat mass and obesity associated (FTO) gene has been found to contribute to the risk of obesity in humans, but the function and regulation of FTO mRNA expression in adipose tissues remain to be clarified. Our aims were to assess the FTO gene expression in subcutaneous and visceral adipose tissues from morbidly obese women and its relation with obesity, insulin resistance indices, and most importantly, to obesity-related inflammatory markers. METHODS: Paired subcutaneous and visceral fat were excised from 33 morbidly obese women and 12 control women who underwent bariatric surgery by laparoscopic gastric by-pass and elective surgery respectively. Adipose tissue mRNA expression was determined by real time RT-PCR. RESULTS: FTO mRNA expression in visceral adipose tissue (VAT) was significantly higher than in subcutaneous adipose tissue (SAT) from obese but not control patients. SAT FTO expression was reduced in obese women compared to control subjects. It correlated negatively with BMI and insulin resistance indices. FTO expression in SAT was positively related to both circulating and mRNA levels of adiponectin, to adiponectin receptor and to PPAR-δexpression, but negatively with IL-6 gene expression and with circulating levels of leptin. FTO in VAT was also positively correlated with adiponectin, adiponectin receptor and PPAR-δ mRNA expression. CONCLUSION: FTO expression in subcutaneous adipose tissue negatively correlates with obesity and insulin resistance. On the other hand, FTO presents a positive association with the expression of adiponectin, an anti-inflammatory adipokine, and with PPAR-δ in both adipose tissues. Taken together, our results suggest that FTO is associated with an anti-inflammatory behaviour in morbid obesity.
BACKGROUND: The fat mass and obesity associated (FTO) gene has been found to contribute to the risk of obesity in humans, but the function and regulation of FTO mRNA expression in adipose tissues remain to be clarified. Our aims were to assess the FTO gene expression in subcutaneous and visceral adipose tissues from morbidly obesewomen and its relation with obesity, insulin resistance indices, and most importantly, to obesity-related inflammatory markers. METHODS: Paired subcutaneous and visceral fat were excised from 33 morbidly obesewomen and 12 control women who underwent bariatric surgery by laparoscopic gastric by-pass and elective surgery respectively. Adipose tissue mRNA expression was determined by real time RT-PCR. RESULTS:FTO mRNA expression in visceral adipose tissue (VAT) was significantly higher than in subcutaneous adipose tissue (SAT) from obese but not control patients. SAT FTO expression was reduced in obesewomen compared to control subjects. It correlated negatively with BMI and insulin resistance indices. FTO expression in SAT was positively related to both circulating and mRNA levels of adiponectin, to adiponectin receptor and to PPAR-δexpression, but negatively with IL-6 gene expression and with circulating levels of leptin. FTO in VAT was also positively correlated with adiponectin, adiponectin receptor and PPAR-δ mRNA expression. CONCLUSION:FTO expression in subcutaneous adipose tissue negatively correlates with obesity and insulin resistance. On the other hand, FTO presents a positive association with the expression of adiponectin, an anti-inflammatory adipokine, and with PPAR-δ in both adipose tissues. Taken together, our results suggest that FTO is associated with an anti-inflammatory behaviour in morbid obesity.
Authors: Sungshim Lani Park; Iona Cheng; Sarah A Pendergrass; Anna M Kucharska-Newton; Unhee Lim; Jose Luis Ambite; Christian P Caberto; Kristine R Monroe; Fredrick Schumacher; Lucia A Hindorff; Matthew T Oetjens; Sarah Wilson; Robert J Goodloe; Shelly-Ann Love; Brian E Henderson; Laurence N Kolonel; Christopher A Haiman; Dana C Crawford; Kari E North; Gerardo Heiss; Marylyn D Ritchie; Lynne R Wilkens; Loïc Le Marchand Journal: Am J Epidemiol Date: 2013-07-02 Impact factor: 4.897
Authors: T Sledzinski; J Korczynska; A Hallmann; L Kaska; M Proczko-Markuszewska; T Stefaniak; M Sledzinski; J Swierczynski Journal: J Endocrinol Invest Date: 2012-11-27 Impact factor: 4.256
Authors: Xiaomin Zhang; Qibin Qi; Cuilin Zhang; Steven R Smith; Frank B Hu; Frank M Sacks; George A Bray; Lu Qi Journal: Diabetes Date: 2012-08-13 Impact factor: 9.461